≥99% HPLC
Triple Agonist
The most advanced multi-receptor compound in metabolic research — studied for its role in appetite regulation, blood sugar balance, and body composition during hormonal transitions.
Dosage
10mg / Vial
Purity
≥99% HPLC
Form
Lyophilized Powder
Availability
In Stock
Select quantity
Adjust quantity
1
Total
€54.90
€54.90
per vial
What is Triple Agonist?
The most advanced multi-receptor compound in metabolic research — studied for its role in appetite regulation, blood sugar balance, and body composition during hormonal transitions. It is offered for controlled in-vitro research only, with clear product information and quality documentation.
≥99% HPLCIndependently tested
Research Purpose
Research suggests this triple-receptor agonist (GLP-1, GIP, glucagon) may produce substantially greater metabolic benefits than single or dual agonists. Studies indicate relevance for weight management and metabolic health in women during perimenopause.
Key Research Findings
Phase 2 trial showed up to 24.2% mean weight loss at 48 weeks
Phase 3 trial demonstrated -20% to -23.7% body weight reduction vs placebo
Studies indicate 72% of prediabetic participants reverted to normoglycemia
Research suggests meaningful liver fat reduction in metabolic liver disease
Quality & Testing
Purity: ≥99% HPLC verified by independent HPLC analysis
Endotoxin tested (LAL method) — bacterial contamination below detection threshold
Batch-specific Certificate of Analysis (COA) provided with every order
100% Janoshik store credit available through our transparency program
Shipping & Storage
EU domestic shipping — no customs delays
Discreet packaging with temperature-controlled options
Store at 2-8°C for optimal stability. Stable at room temperature for up to 48h during transit
Free shipping on orders over €300
For research purposes only. This product is sold exclusively for in-vitro research and is not for human or animal consumption.